You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Disrupting the medical industry has enormous upside.
Hims & Hers (HIMS 0.85%) has been on a growth tear as it reaches more customers and customizes offerings in ways traditional pharmacies can't. And those advantages open up an enormous market for the company. In this video, Travis Hoium digs into the competitive advantage and how Hims & Hers keeps growing.
*Stock prices used were end-of-day prices of June 24, 2024. The video was published on June 25, 2024.
Travis Hoium has positions in Hims & Hers Health. The Motley Fool has positions in and recommends Target. The Motley Fool has a disclosure policy. Travis Hoium is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through their link, they will earn some extra money that supports their channel. Their opinions remain their own and are unaffected by The Motley Fool.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
